Showing results (1-10 of 1,067) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|November 27, 2002
Assessment of type I error rates for the statistical sub-model in NONMEMUlrika Wählby, M René Bouw, E Niclas Jonsson, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 27, 2002
Bayesian analysis of population PK/PD models: general concepts and softwareDavid J Lunn, Nicky Best, Andrew Thomas, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 31, 2001
On sample size calculation in bioequivalence trialsS C Chow, H WangJournal of Pharmacokinetics and Pharmacodynamics|January 5, 2002
A stochastic model describes the heterogeneous pharmacokinetics of cyclosporinL Claret, A Iliadis, P MacherasJournal of Pharmacokinetics and Pharmacodynamics|January 5, 2002
Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored dataJ P Hing, S G Woolfrey, D Greenslade, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmiaJ Shi, T M Ludden, A P Melikian, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 20, 2021
Improving categorical endpoint longitudinal exposure-response modeling through the joint modeling with a related endpointChuanpu Hu, Honghui ZhouJournal of Pharmacokinetics and Pharmacodynamics|March 16, 2021
Mathematical modeling of mammalian circadian clocks affecting drug and disease responsesPanteleimon D Mavroudis, William J JuskoJournal of Pharmacokinetics and Pharmacodynamics|March 17, 2021
Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignanciesFeng Yang, Anne J Paccaly, Ronda K Rippley, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2021
A semi-mechanistic exposure-response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseasesJacob Leander, Mikael Sunnåker, Dinko Rekić, et al.Pageof 107